John Janik

John Janik is an experienced professional in the field of clinical development and medicine. Currently serving as Head of Biotherapeutics at Incyte, John previously held roles at Cullinan Oncology, Augusta University, Bristol-Myers Squibb, and the National Cancer Institute. With a Doctor of Medicine degree from The Ohio State University College of Medicine and a Bachelor of Science degree in Physics from John Carroll University, John has a strong educational background to support their extensive career in clinical trials and research.